Anavex Life Sciences Corp (AVXL)

[Steady_T]

One would hope that with all the data that is being collected in the various trials Anavex would be gaining a bit of understanding of why there are such differences. If you look at the other outcome measures in all the trials you see that Anavex is collecting a huge amount of data over what would strictly be required for the trial.

One of the things I like about the way Anavex does its trials is that it treats each one like a research project as well as a drug trial targeted at approval. To me this is another example of how MIssling manages money effectively.

So far there has been no mention of dosing more than once a day with 2-73. I wonder if the company has considered that. I suppose that would require an additional trial.